Samphire Neuroscience is a pioneering neurotechnology company dedicated to transforming women's health through innovative wearable solutions. Founded in 2021 and headquartered in London, United Kingdom, the company focuses on developing scientifically validated devices that empower women to manage menstrual-related challenges effectively.
Background
Samphire Neuroscience's mission is to create a world where women have access to advanced neurotechnology tailored to their health needs without compromising on design or lifestyle. Leveraging over 30 years of research and clinical expertise, the company has developed "Nettle," the world's first wearable neurotechnology designed for at-home alleviation of premenstrual syndrome (PMS) and period pain symptoms. Nettle is available for purchase in the UK and across the EU and is undergoing clinical trials for premenstrual dysphoric disorder (PMDD) and endometriosis populations. Additionally, Samphire offers neuroscience-backed cycle tracking through the Samphire app, available on the Apple App Store and Google Play.
Key Strategic Focus
The company's strategic focus centers on developing wearable neurotechnology solutions that address menstrual-cycle-related challenges. By integrating advanced neuroscience with user-friendly design, Samphire aims to provide non-invasive, effective alternatives to traditional pain management methods. Their primary market includes women seeking innovative solutions for menstrual health issues, with a particular emphasis on conditions like PMS, PMDD, and endometriosis.
Financials and Funding
Since its inception, Samphire Neuroscience has successfully secured funding to support its research and development initiatives. The company raised a total of $2.3 million in funding over one round. In June 2025, Samphire announced a $5 million Series A funding round to further develop and expand its product offerings. Notable investors include SOSV, a global venture capital firm known for supporting innovative startups. The capital raised is intended to enhance product development, conduct clinical trials, and expand market reach.
Pipeline Development
Samphire's flagship product, Nettle, is currently available in the UK and EU markets for managing PMS and period pain. The device is also undergoing clinical trials targeting PMDD and endometriosis, with anticipated milestones including regulatory approvals and expanded market availability in the coming years.
Technological Platform and Innovation
Samphire Neuroscience distinguishes itself through its proprietary wearable neurotechnology platform. The Nettle device utilizes non-invasive neuromodulation techniques to alleviate menstrual pain and associated symptoms. The company's approach combines advanced neuroscience research with user-centric design, ensuring that the technology seamlessly integrates into users' lifestyles.
Leadership Team
- Alex Cook, Co-Founder: Brings extensive experience in neurotechnology development and a passion for women's health innovation.
- Emilė Radytė, Co-Founder: Combines expertise in neuroscience and product development, focusing on creating user-friendly health solutions.
Leadership Changes
As of the latest available information, there have been no significant changes or appointments within the company's leadership team.
Competitor Profile
Market Insights and Dynamics
The women's health technology market is experiencing significant growth, driven by increasing awareness and demand for innovative solutions addressing menstrual health issues. The global femtech market is projected to reach substantial valuations, with a compound annual growth rate (CAGR) reflecting the expanding opportunities in this sector.
Competitor Analysis
Key competitors in the women's health neurotechnology space include:
- Livia: Offers a wearable device that uses electrical nerve stimulation to relieve menstrual pain.
- ThermaCare: Provides heat wraps designed to alleviate menstrual cramps through heat therapy.
- Elvie: Develops smart technology products for women's health, including pelvic floor trainers and breast pumps.
These companies focus on various aspects of menstrual health management, utilizing technologies ranging from electrical stimulation to heat therapy.
Strategic Collaborations and Partnerships
Samphire Neuroscience has established partnerships with leading research institutions and healthcare providers to validate and enhance its product offerings. Collaborations with organizations like SOSV have provided both financial support and strategic guidance, enabling the company to accelerate its growth and innovation efforts.
Operational Insights
In relation to major competitors, Samphire's distinct competitive advantage lies in its integration of advanced neuroscience with wearable technology specifically designed for women's health. The company's focus on non-invasive, user-friendly solutions positions it favorably in the market, catering to a growing demand for effective menstrual health management tools.
Strategic Opportunities and Future Directions
Looking ahead, Samphire Neuroscience aims to expand its product line to address a broader range of women's health issues beyond menstrual pain. Potential areas of development include solutions for menopause symptoms and hormonal imbalances. The company's strong foundation in neuroscience and commitment to innovation position it well to capitalize on emerging opportunities in the women's health technology sector.
Contact Information
- Website: samphireneuro.com
- LinkedIn: Samphire Neuroscience
- Twitter: @samphireneuro
- Instagram: @samphireneuro
For further inquiries, please visit the company's official website or social media profiles.
